<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00966264</url>
  </required_header>
  <id_info>
    <org_study_id>Finnish Academy-project 29168</org_study_id>
    <nct_id>NCT00966264</nct_id>
  </id_info>
  <brief_title>Hysterectomy and Levonorgestrel Releasing Intrauterine System (LNG-IUS) in the Treatment of Menorrhagia</brief_title>
  <acronym>VUOKKO</acronym>
  <official_title>Hysterectomy and Levonorgestrel-releasing IUS in the Treatment of Menorrhagia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helsinki University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Eastern Finland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Oulu</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Tampere</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Turku</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Helsinki University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomised study including 236 women referred for essential menorrhagia to five university
      hospitals in Finland was conducted to compare the cost-effectiveness and the quality of life
      issues in the treatment of menorrhagia.Participants were randomly assigned to treatment with
      LNG-IUS (n=119), or hysterectomy (n=117), and were monitored for ten years. The primary
      outcome measures were health related quality of life (HRQoL), other measures of psychosocial
      well-being (anxiety, depression, sexual functioning), and costs.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized VUOKKO trial was conducted between 1994-2008 to study hysterectomy and LNG-IUS
      in the treatment of menorrhagia.Overall, 236 women aged 35 to 49 years who were menstruating,
      had completed their family size, and were eligible for both treatments were randomized to
      either receive a LNG-IUS (n=119) or undergo hysterectomy (n=117). The follow-up visits took
      place six months and 12 months after the treatment, and again five and ten years after the
      randomization. The primary outcome measures were health related quality of life (HRQoL),
      other measures of psychosocial well-being (anxiety, depression, sexual functioning), and
      costs. The amount of menstrual blood loss was objectively measured before treatment and after
      one and five years. The one year the results were published in 2001 (Lancet 2001;357:273) and
      the five year results in 2004 (JAMA 2004; 291:1456).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 1994</start_date>
  <completion_date type="Actual">October 2008</completion_date>
  <primary_completion_date type="Actual">October 2008</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>HRQoL (Health Related Quality of Life)</measure>
    <time_frame>baseline and 5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Costs</measure>
    <time_frame>baseline, 6 and 12 months, 5 and 10 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Depression</measure>
    <time_frame>baseline, 6 and 12 months, 5 and 10 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">236</enrollment>
  <condition>Menorrhagia</condition>
  <arm_group>
    <arm_group_label>LNG-IUS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Levonorgestrel releasing intrauterine system</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hysterectomy</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Hysterectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>LNG-IUS</intervention_name>
    <description>LNG-IUS releasing 25 microg of levonorgestrel</description>
    <arm_group_label>LNG-IUS</arm_group_label>
    <arm_group_label>Hysterectomy</arm_group_label>
    <other_name>Mirena</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hysterectomy</intervention_name>
    <description>operation</description>
    <arm_group_label>LNG-IUS</arm_group_label>
    <arm_group_label>Hysterectomy</arm_group_label>
    <other_name>Removal of uterus by laparoscopy, vaginally or abdominally</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  heavy menstrual bleeding

          -  35-49 years

          -  were menstruating

          -  had completed their family size

          -  were eligible for both treatments

        Exclusion Criteria:

          -  submucous fibroids

          -  endometrial polyps

          -  ovarian tumours or cysts,

          -  cervical pathology

          -  urinary and bowel symptoms or pain due to large fibroids

          -  lack of indication for hysterectomy

          -  history of malignancies

          -  menopause

          -  severe depression

          -  metrorrhagia as a main complaint

          -  previous treatment failure with LNG-IUS

          -  severe acne

          -  uterine malformation
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>49 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ritva S Hurskainen, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Helsinki University Central Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jorma Paavonen, prof</last_name>
    <role>Study Director</role>
    <affiliation>Helsinki University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Juha Teperi, prof</last_name>
    <role>Study Chair</role>
    <affiliation>National Istitute For Health and Welfare, Finland</affiliation>
  </overall_official>
  <verification_date>August 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 20, 2009</study_first_submitted>
  <study_first_submitted_qc>July 24, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 26, 2009</study_first_posted>
  <results_first_submitted>January 20, 2009</results_first_submitted>
  <results_first_submitted_qc>July 24, 2009</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 26, 2009</results_first_posted>
  <last_update_submitted>August 26, 2009</last_update_submitted>
  <last_update_submitted_qc>August 26, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 2, 2009</last_update_posted>
  <responsible_party>
    <name_title>Ritva Hurskainen, project manager</name_title>
    <organization>Helsinki University Hospital</organization>
  </responsible_party>
  <keyword>randomized controlled trial</keyword>
  <keyword>menorrhagia</keyword>
  <keyword>LNG-IUS</keyword>
  <keyword>hysterectomy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Menorrhagia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Levonorgestrel</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Two hundred and thirty-six women referred for essential menorrhagia to five university hospitals in Finland were randomly assigned to treatment with LNG-IUS (n= 119) or hysterectomy (n=117).</recruitment_details>
      <pre_assignment_details>All randomised women were analysed as intention-to-treat</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>LNG-IUS</title>
          <description>Levonorgestrel releasing intrauterine system (LNG-IUS)</description>
        </group>
        <group group_id="P2">
          <title>Hysterectomy</title>
          <description>Hysterectomy (abdominal,laparoscopical or vaginal)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="119"/>
                <participants group_id="P2" count="117"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="115">5 years results</participants>
                <participants group_id="P2" count="114">5 years results</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>LNG-IUS</title>
          <description>Levonorgestrel releasing intrauterine system (LNG-IUS)</description>
        </group>
        <group group_id="B2">
          <title>Hysterectomy</title>
          <description>Hysterectomy (abdominal,laparoscopical or vaginal)</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="119"/>
            <count group_id="B2" value="117"/>
            <count group_id="B3" value="236"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="119"/>
                    <measurement group_id="B2" value="117"/>
                    <measurement group_id="B3" value="236"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43.1" spread="3.5"/>
                    <measurement group_id="B2" value="43.0" spread="3.2"/>
                    <measurement group_id="B3" value="43" spread="3.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="119"/>
                    <measurement group_id="B2" value="117"/>
                    <measurement group_id="B3" value="236"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>HRQoL (Health Related Quality of Life)</title>
        <description>HRQoL was measured by the 5-Dimensional EuroQol (EQ-5D) questionnaire which measures HRQoL in 5 dimensions of life (scale 0-1)(from very poor=0 to very good=5). The results are the change of HRQoL from baseline at 5 years (EQ-5D score at 5 years - EQ-5D score at baseline)</description>
        <time_frame>baseline and 5 years</time_frame>
        <population>The power calculation was made on the basis of an EQ-5D score SD of 19% and alfa=0.05. The study had 80% power to detect a 7.5% difference between the groups</population>
        <group_list>
          <group group_id="O1">
            <title>LNG-IUS</title>
            <description>Levonorgestrel releasing intrauterine system (LNG-IUS)</description>
          </group>
          <group group_id="O2">
            <title>Hysterectomy</title>
            <description>Hysterectomy (abdominal,laparoscopical or vaginal)</description>
          </group>
        </group_list>
        <measure>
          <title>HRQoL (Health Related Quality of Life)</title>
          <description>HRQoL was measured by the 5-Dimensional EuroQol (EQ-5D) questionnaire which measures HRQoL in 5 dimensions of life (scale 0-1)(from very poor=0 to very good=5). The results are the change of HRQoL from baseline at 5 years (EQ-5D score at 5 years - EQ-5D score at baseline)</description>
          <population>The power calculation was made on the basis of an EQ-5D score SD of 19% and alfa=0.05. The study had 80% power to detect a 7.5% difference between the groups</population>
          <units>points on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="115"/>
                <count group_id="O2" value="114"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.08" lower_limit="0.03" upper_limit="0.13"/>
                    <measurement group_id="O2" value="0.10" lower_limit="0.05" upper_limit="0.15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Costs</title>
        <time_frame>baseline, 6 and 12 months, 5 and 10 years</time_frame>
        <posting_date>05/2010</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Depression</title>
        <time_frame>baseline, 6 and 12 months, 5 and 10 years</time_frame>
        <posting_date>05/2010</posting_date>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>LNG-IUS</title>
          <description>Levonorgestrel releasing intrauterine system (LNG-IUS)</description>
        </group>
        <group group_id="E2">
          <title>Hysterectomy</title>
          <description>Hysterectomy (abdominal,laparoscopical or vaginal)</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0"/>
                <counts group_id="E2" subjects_affected="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>bladder perforation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="109"/>
              </event>
              <event>
                <sub_title>peritonitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="109"/>
              </event>
              <event>
                <sub_title>vesicovaginal fistula</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="109"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>20</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="80"/>
                <counts group_id="E2" subjects_affected="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>hormonal symptoms</sub_title>
                <counts group_id="E1" events="18" subjects_affected="18" subjects_at_risk="119"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="117"/>
              </event>
              <event>
                <sub_title>menstrual bleeding problems</sub_title>
                <counts group_id="E1" events="61" subjects_affected="61" subjects_at_risk="119"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="117"/>
              </event>
              <event>
                <sub_title>wund infection</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="50"/>
                <counts group_id="E2" events="20" subjects_affected="20" subjects_at_risk="109"/>
              </event>
              <event>
                <sub_title>perioperative bleeding</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="109"/>
              </event>
              <event>
                <sub_title>postoperative bleeding</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="50"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="109"/>
              </event>
              <event>
                <sub_title>urinary retention</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="119"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="117"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Ritva Hurskainen</name_or_title>
      <organization>Helsinki University</organization>
      <phone>+23845872267</phone>
      <email>ritva.hurskainen@hus.fi</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

